Australia Chondroitin Sulfate Market Size & Outlook
Australia chondroitin sulfate market, 2017-2030 (US$M)
Related Markets
Australia chondroitin sulfate market highlights
- The Australia chondroitin sulfate market generated a revenue of USD 34.5 million in 2022 and is expected to reach USD 46.4 million by 2030.
- The Australia market is expected to grow at a CAGR of 3.8% from 2023 to 2030.
- In terms of segment, bovine was the largest revenue generating source in 2022.
- Synthetic is the most lucrative source segment registering the fastest growth during the forecast period.
Chondroitin sulfate market data book summary
| Market revenue in 2022 | USD 34.5 million |
| Market revenue in 2030 | USD 46.4 million |
| Growth rate | 3.8% (CAGR from 2022 to 2030) |
| Largest segment | Bovine |
| Fastest growing segment | Synthetic |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bovine, Swine, Poultry, Shark, Synthetic |
| Key market players worldwide | Merck KGaA, BRF SA ADR, Seikagaku, TSI Group, Bioiberica, Bio-gen Extracts |
Other key industry trends
- In terms of revenue, Australia accounted for 2.8% of the global chondroitin sulfate market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China chondroitin sulfate market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 91.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chondroitin Sulfate Market Scope
Chondroitin Sulfate Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia chondroitin sulfate market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chondroitin sulfate market will help companies and investors design strategic landscapes.
Bovine was the largest segment with a revenue share of 37.97% in 2022. Horizon Databook has segmented the Australia chondroitin sulfate market based on bovine, swine, poultry, shark, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
Australia is one of the prominent producers and suppliers of high-quality red meat. Chondroitin sulfate is mostly sourced from bovine and is used to boost joint health and thus, is majorly consumed by nutraceutical sector. In addition, increasing opportunities for chondroitin sulfate from animal and aquafeed additives industry and from pet food ingredients are expected to augment the market growth.
Majority of the trachea is exported from Australia to China for the extraction of sodium chondroitin sulfate. Chondroitin sulfate products manufactured in China are reported to be of low purity and low quality by international consumers, which provides substantial opportunity for Australian red meat processors to supply uniform and high-quality chondroitin sulfate to the international markets.
Reasons to subscribe to Australia chondroitin sulfate market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia chondroitin sulfate market databook
-
Our clientele includes a mix of chondroitin sulfate market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia chondroitin sulfate market , including forecasts for subscribers. This country databook contains high-level insights into Australia chondroitin sulfate market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia chondroitin sulfate market size, by source, 2017-2030 (US$M)
Australia Chondroitin Sulfate Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
